Multiple Sclerosis (MS) Drugs
Avonex ® (interferon beta-1a)
MS Drugs - Avonex ® Efficacy (Effectiveness of Avonex ®)
How effective is Avonex ®?
| % of patients progressing In disability at 2 years | |
| Placebo | Avonex ® |
| 34.9 % | 21.9 % |
Number of exacerbations in Subset (people who completed full 2 years) completing 2 years of Avonex ®
| No. of exacerbations | Placebo | Avonex ® |
| 0 | 26% | 38% |
| 1 | 30% | 31% |
| 2 | 11% | 18% |
| 3 | 14% | 7% |
| 4 | 18% | 7% |
Ref: Jacobs LD, et al, Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996;39(3):285-94:
Ref: Avonex® prescribing information